10 : Carbapenem Resistance in and Other Members of the Family

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Carbapenem Resistance in and Other Members of the Family , Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815585/9781555813772_Chap10-1.gif /docserver/preview/fulltext/10.1128/9781555815585/9781555813772_Chap10-2.gif


with reduced susceptibility to carbapenems are an emerging, worldwide problem. In most cases, the reduced carbapenem susceptibility is attributable to acquisition of one of a variety of ß-lactamases with carbapenem-hydrolyzing properties. Carbapenem resistance can be mediated by the acquisition of carbapenem-hydrolyzing ß-lactamases. In Japan, IMP enzymes have been recovered from isolates of and and conferred resistance to ceftazidime and imipenem. Occasional isolates of carrying IMP metallo-ß-lactamases have also been recovered in Japan. carrying KPC ß-lactamases are emerging and pose serious challenges to therapy. Approximately 90%of KPC-possessing isolates are susceptible to polymyxin B, and the antibiotic exhibits a concentration-dependent killing effect. The addition of rifampin to polymyxin B provided bactericidal activity in 15/16 tested isolates in one report and resulted in a lower inhibitory concentration of polymyxin B. The fact that other carbapenem-hydrolyzing enzymes emerged prior to the commercial release of carbapenems also suggests that other properties of these enzymes may justify their existence or that other antibiotics in nature could be substrates and exert selection pressures. Also complicating potential antibiotic control strategies is the fact that other resistance genes often accompany the carbapenemase gene, including those for other ß-lactamases, amikacin, gentamicin, streptomycin, tobramycin, and trimethoprim-sulfamethoxazole. Due to these associations, it has been suggested that selective pressure from non-ß-lactam antibiotics (e.g., aminoglycosides) may encourage concomitant carbapenem resistance.

Citation: Bratu S, Quale J. 2007. Carbapenem Resistance in and Other Members of the Family , p 181-197. In Scheld W, Hooper D, Hughes J (ed), Emerging Infections 7. ASM Press, Washington, DC. doi: 10.1128/9781555815585.ch10
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


1. Arakawa, Y.,, N. Shibata,, K. Shibayama,, H. Kurokawa,, T. Yagi,, H. Fujiwara, and, M. Goto. 2000. Convenient test for screening metallo-β-lactamase-producing gram-negative bacteria by using thiol compounds. J. Clin. Microbiol. 38: 4043.
2. Bornet, C.,, A. Davin-Regli,, C. Bosi,, J.-M. Pages, and, C. Bollet. 2000. Imipenem resistance of Enterobacter aerogenes mediated by outer membrane permeability. J. Clin. Microbiol. 38: 10481052.
3. Bradford, P. A.,, S. Bratu,, C. Urban,, M. Visalli,, N. Mariano,, D. Landman,, J. J. Rahal,, S. Brooks,, S. Cebular, and, J. Quale. 2004. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City. Clin. Infect. Dis. 39: 5560.
4. Bradford, P. A.,, C. Urban,, N. Mariano,, S. J. Projan,, J. J. Rahal, and, K. Bush. 1997. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrob. Agents Chemother. 41: 563569.
5. Bratu, S.,, D. Landman,, M. Alam,, E. Tolentino, and, J. Quale. 2005. Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York. Antimicrob. Agents Chemother. 49: 776778.
6. Bratu, S.,, D. Landman,, R. Haag,, R. Recco,, A. Eramo,, M. Alam, and, J. Quale. 2005. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: A new threat to our antibiotic armamentarium. Arch. Intern. Med. 165: 14301435.
7. Bratu, S.,, P. Tolaney,, U. Karamudi,, J. Quale,, M. Mooty,, S. Nichani, and, D. Landman. 2005. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in-vitro activity of polymyxin B and other agents. J. Antimicrob. Chemother. 56: 128132.
8. Bratu, S.,, M. Mooty,, S. Nichani,, D. Landman,, C. Gullans,, B. Pettinato,, U. Karumudi,, P. Tolaney, and, J. Quale. 2005. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob. Agents Chemother. 49: 30183020.
9. Bush, K.,, S. K. Tanaka,, D. P. Bonner, and, R. B. Sykes. 1985. Resistance caused by decreased penetration of β-lactam antibiotics into Enterobacter cloacae. Antimicrob. Agents Chemother. 27: 555560.
10. Canton, R.,, T. M. Coque, and, F. Baquero. 2003. Multi-resistant Gram-negative bacilli: from epidemics to endemics. Curr. Opin. Infect. Dis. 16: 315325.
11. Cao, V. T. B.,, G. Arlet,, B. M. Ericsson,, A. Tammelin,, P. Courvalin, and, T. Lambert. 2000. Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alteration. J. Antimicrob. Chemother. 46: 895900.
12. Centers for Disease Control and Prevention. 2004. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004. Am. J. Infect. Control 32: 470485.
13. Chow, J. W., and, D. M. Shlaes. 1991. Imipenem resistance associated with the loss of a 40 kDa outer membrane protein in Enterobacter aerogenes. J. Antimicrob Chemother. 28: 499504.
14. Chu, Y.-W.,, M. Afzal-Shah,, E. T. S. Houang,, M.-F. I. Palepou,, D. J. Lyon,, N. Woodford, and, D. M. Livermore. 2001. IMP-4, a novel metallo-β-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob. Agents Chemother. 45: 710714.
15. Crowley, B.,, V. J. Benedi, and, A. Domenech-Sanchez. 2002. Expression of SHV-2 β-lactamase and of reduced amounts of OmpK36 porin in Klebsiella pneumoniae results in increased resistance to cephalosporins and carbapenems. Antimicrob. Agents Chemother. 46: 36793682.
16. de Champs, C.,, C. Henquell,, D. Guelon,, D. Sirot,, N. Gazuy, and, J. Sirot. 1993. Clinical and bacteriological study of nosocomial infections due to Enterobacter aerogenes resistant to imipenem. J. Clin. Microbiol. 31: 123127.
17. Domenech-Sanchez, A.,, S. Hernandez-Alles,, L. Martinez-Martinez,, V. J. Benedi, and, S. Alberti. 1999. Identification and characterization of a new porin gene of Klebsiella pneumoniae: its role in β-lactam antibiotic resistance. J. Bacteriol. 181: 27262732.
18. Falagas, M. E., and, S. K. Kasiakou. 2005. Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections. Clin. Infect. Dis. 40: 13331341.
19. Franceschini, N.,, B. Caravelli,, J. D. Docquier,, M. Galleni,, J. M. Frere,, G. Amicosante, and, G. M. Rossolini. 2000. Purification and biochemical characterization of the VIM-1 metallo-beta-lactamase. Antimicrob. Agents Chemother. 44: 30033007.
20. Hanberger, H.,, J.-A. Garcia-Rodriguez,, M. Gobernado,, H. Goossens,, L. E. Nilsson,, M. J. Struelens and the French and Portuguese ICU Study Groups. 1999. Antibiotic susceptibility among aerobic Gram-negative bacilli in intensive care units in 5 European countries. JAMA 281: 6771.
21. Hernandez-Alles, S.,, S. Alberti,, D. Alvarez,, A. Domenech-Sanchez,, L. Martinez-Martinez,, J. Gil,, J. M. Tomas, and, V. J. Benedi. 1999. Porin expression in clinical isolates of Klebsiella pneumoniae. Microbiology 145: 673679.
22. Hirakata, Y.,, K. Izumikawa,, T. Yamaguchi,, H. Takemura,, H. Tanaka,, R. Yoshida,, J. Matsuda,, M. Nakano,, K. Tomono,, S. Maesaki,, M. Kaku,, Y. Yamada,, S. Kamihira, and, S. Kohno. 1998. Rapid detection and evaluation of clinical characteristics of emerging multiple-drug-resistant gram-negative rods carrying the metallo-β-lactamase gene blaIMP. Antimicrob. Agents Chemother. 42: 20062011.
23. Hong, T.,, E. S. Moland,, B. Abdalhamid,, N. D. Hanson,, J. Wang,, C. Sloan,, D. Fabian,, A. Farajallah,, J. Levine, and, K. S. Thomson. 2005. Escherichia coli: development of carbapenem resistance during therapy. Clin. Infect. Dis. 40: e84e86.
24. Hossain, A.,, M. J. Ferraro,, R. M. Pino,, R. B. Dew III,, E. S. Moland,, T. J. Lockhart,, K. S. Thomson,, R. V. Goering, and, N. D. Hanson. 2004. Plasmid-mediated carbapenem hydrolyzing enzyme KPC-2 in Enterobacter sp. Antimicrob. Agents Chemother. 48: 44384440.
25. Jones, R. N.,, L. M. Desphande,, J. M. Bell,, J. D. Turnidge,, S. Kohno,, Y. Hirakata,, Y. Ono,, Y. Miyazawa,, S. Kawakama,, M. Inoue,, Y. Hirata, and, M. A. Toleman. 2004. Evaluation of the contemporary occurrence rates of metallo-β-lactamases in multidrug-resistant gram-negative bacilli in Japan: report from the SENTRY Antimicrobial Surveillance Program (1998–2002). Diagn. Microbiol. Infect. Dis. 49: 289294.
26. Karabinis, A.,, E. Paramythiotou,, D. Mylona-Petropoulou,, A. Kalogeromitros,, N. Katsarelis,, F. Kontopidou,, I. Poularas, and, H. Malamou-Lada. 2005. Colistin for Klebsiella pneumoniae-associated sepsis. Clin. Infect. Dis. 38: e7e9.
27. Karlowsky, J. A.,, M. E. Jones,, C. Thornsberry,, I. R. Friedland, and, D. F. Sahm. 2003. Trends in antimicrobial susceptibilities among Enterobacteriaceae isolated from hospitalized patients in the United States from 1998 to 2001. Antimicrob. Agents Chemother. 47: 16721680.
28. Koh, T. H.,, L. H. Sng,, G. S. Babini,, N. Woodford,, D. M. Livermore, and, L. M. C. Hall. 2001. Carbapenem-resistant Klebsiella pneumoniae in Singapore producing IMP-1 β-lactamase and lacking an outer membrane protein. Antimicrob. Agents Chemother. 45: 19391940.
29. Kurokawa, H.,, T. Yagi,, N. Shibata,, K. Shibayama, and, Y. Arakawa. 1999. Worldwide proliferation of carbapenem-resistant gram-negative bacteria. Lancet 354: 955.
30. Laraki, N.,, N. Franceschini,, G. M. Rossolini,, P. Santucci,, C. Meunier,, E. de Pauw,, G. G. Amicosante,, J. M. Frere, and, M. Galeni. 1999. Biochemical characterization of the Pseudomonas aeruginosa 101/1477 metallo-β-lactamase IMP-1 produced by Escherichia coli. Antimicrob. Agents Chemother. 43: 902906.
31. Lee, E. H.,, M. H. Nicolas,, M. D. Kitzis,, G. Pialoux,, E. Collatz, and, L. Gutmann. 1991. Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem. Antimicrob. Agents Chemother. 35: 10931098.
32. Lee, K.,, G. Y. Ha,, B. M. Shin,, J. J. Kim,, J. O. Kang,, S. J. Jang,, D. Y. Yong,, Y. Chong and the Korean Nationwide Surveillance of Antimicrobial Resistance (KONSAR) Group. 2004. Metallo-β-lactamase-producing gram-negative bacilli in Korean Nationwide Surveillance of Antimicrobial Resistance Group hospitals in 2003: continued prevalence of VIM-producing Pseudomonas spp. and increase in IMP-producing Acinetobacter spp. Diagn. Microbiol. Infect. Dis. 50: 5158.
33. Lee, K.,, Y. S. Lim,, D. Yong,, J. H. Yum, and, Y. Chung. 2003. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-β-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 41: 46234629.
34. Levin, A. S.,, A. A. Barone,, J. Penco,, M. V. Santos,, I. S. Marinho,, E. A. G. Arruda,, E. I. Manrique, and, S. F Costa. 1999. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin. Infect. Dis. 28: 10081011.
35. Luzzaro, F.,, J.-D. Docquier,, C. Colinon,, A. Endimiani,, G. Lombardi,, G. Amicosante,, G. M. Rossolini, and, A. Toniolo. 2004. Emergence in Klebsiella pneumoniae and Enterobacter cloacae clinical isolates of the VIM-4 metallo-β-lactamase encoded by a conjugative plasmid. Antimicrob. Agents Chemother. 48: 648650.
36. Mainardi, J.-L.,, P. Mugnier,, A. Coutrot,, A. Buu-Hoi,, E. Collatz, and, L. Gutmann. 1997. Carbapenem resistance in a clinical isolate of Citrobacter freundii. Antimicrob. Agents Chemother. 41: 23522354.
37. Martinez-Martinez, L.,, A. Pascual,, S. Hernandez-Alles,, D. Alvarez-Diaz,, A. I. Suarez,, J. Tran,, V. J. Benedi, and, G. A. Jacoby. 1999. Roles of β-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob. Agents Chemother. 43: 16691673.
38. Mehtar, S.,, A. Tsakris, and, T. L. Pitt. 1991. Imipenem resistance in Proteus mirabilis. J. Antimicrob. Chemother. 28: 612615.
39. Miriagou, V.,, E. Tzelepi,, D. Gianneli, and, L. S. Tzouvelekis. 2003. Escherichia coli with a self-transferable, multiresistant plasmid coding for metallo-β-lactamase VIM-1. Antimicrob. Agents Chemother. 47: 395397.
40. Miriagou, V.,, L. S. Tzouvelekis,, S. Rossiter,, E. Tzelepi,, F. J. Angulo, and, J. M. Whichard. 2003. Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. Antimicrob. Agents Chemother. 47: 12971300.
41. Moland, E. S.,, J. A. Black,, J. Ourada,, M. D. Reisbig,, N. D. Hanson, and, K. S. Thomson. 2002. Occurrence of newer β-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals. Antimicrob. Agents Chemother. 46: 38373842.
42. Moland, E. S.,, N. D. Hanson,, V. L. Herrera,, J. A. Black,, T. J. Lockhart,, A. Hossain,, J. J. Johnson,, R. V. Goering, and, K. S. Thomson. 2003. Plasmid-mediated, carbapenem-hydrolysing β-lactamase, KPC-2, in Klebsiella pneumoniae isolates. J. Antimicrob. Chemother. 51: 711714.
43. Naas, T., and, P. Nordmann. 1994. Analysis of a carbapenem-hydrolyzing class A β-lactamase from Enterobacter cloacae and of its LysR-type regulatory protein. Proc. Natl. Acad. Sci. 91: 76937697.
44. Naas, T.,, L. Vandel,, W. Sougakoff,, D. M. Livermore, and, P. Nordmann. 1994. Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing class A β-lactamase, Sme-1, from Serratia marcescens S6. Antimicrob. Agents Chemother. 38: 12621270.
45. Nordmann, P.,, S. Mariotte,, T. Naas,, R. Labia, and, M. H. Nicolas. 1993. Biochemical properties of a carbapenem-hydrolyzing β-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli. Antimicrob. Agents Chemother. 37: 939946.
46. Peterson, P. J.,, N. V. Jacobus,, W. J. Weiss,, P. E. Sum, and, R. T. Testa. 1999. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9- t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob. Agents Chemother. 43: 738744.
47. Poirel, L.,, C. Heritier,, V. Tolun., and, P. Nordmann. 2004. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48: 1522.
48. Poirel, L.,, T. Naas,, D. Nicolas,, L. Collet,, S. Bellais,, J. D. Cavallo, and, P. Nordmann. 2000. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase, and its plasmid- and integronborne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44: 891897.
49. Poirel, L., and, P. Nordmann. 2002. Acquired carbapenem-hydrolyzing beta-lactamases and their genetic support. Curr. Pharmaceut. Biotechnol. 3: 117121.
50. Poirel, L.,, J. N. Pham,, L. Cabanne,, B. J. Gatus,, S. M. Bell, and, P. Nordmann. 2004. Carbapenem-hydrolysing metallo-β-lactamases from Klebsiella pneumoniae and Escherichia coli isolated in Australia. Pathology 36: 366367.
51. Poirel, L.,, G. F. Weldhagen,, T. Naas,, C. De Champs,, M. G. Dove, and, P. Nordmann. 2001. GES-2, a class A β-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem. Antimicrob. Agents Chemother. 45: 25982603.
52. Pottumarthy, S.,, E. Smith Moland,, S. Juretschko,, S. R. Swanzy,, K. S. Thomson, and, T. R. Fritsche. 2003. NmcA carbapenem-hydrolyzing enzyme in Enterobacter cloacae in North America. Emerg. Infect. Dis. 9: 9991002.
53. Quale, J.,, D. Landman,, P. A. Bradford,, M. Visalli,, J. Ravishankar,, C. Flores,, D. Mayorga,, K. Vangala, and, A. Adedeji. 2002. Molecular epidemiology of a citywide outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae infection. Clin. Infect. Dis. 35: 834841.
54. Queenan, A. M.,, C. Torres-Viera,, H. S. Gold,, Y. Carmeli,, G. M. Eliopoulos,, R. C. Moellering, Jr.,, J. P. Quinn,, J. Hindler,, A. A. Medeiros, and, K. Bush. 2000. SME-type carbapenem-hydrolyzing class A betalactamases from geographically diverse Serratia marcescens strains. Antimicrob. Agents Chemother. 44: 30353039.
55. Raimondi, A.,, A. Traverso, and, H. Nikaido. 1991. Imipenem- and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgeri lack porins. Antimicrob. Agents Chemother. 35: 11741180.
56. Rasmussen, B. A.,, K. Bush,, D. Keeney,, Y. Yang,, R. Hare,, C. O’Gara, and, A. A. Medeiros. 1996. Characterization of IMI-1 beta-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae. Antimicrob. Agents Chemother. 40: 20802086.
57. Richards, M. J.,, J. R. Edwards,, D. H. Culver,, R. P. Gaynes and the National Nosocomial Infections Surveillance System. 1999. Nosocomial infections in medical intensive care units in the United States. Crit. Care Med. 27: 887892.
58. Sader, H. S.,, D. J. Biedenbach, and, R. N. Jones. 2003. Global patterns of susceptibility for 21 commonly utilized antimicrobial agents tested against 48,440 Enterobacteriaceae in the SENTRY Antimicrobial Surveillance Program (1997–2001). Diagn. Microbiol. Infect. Dis. 47: 361364.
59. Senda, K.,, Y. Arakawa,, S. Ichiyama,, K. Nakashima,, H. Ito,, S. Ohsuka,, K. Shimokata,, N. Kato, and, M. Ohta. 1996. PCR detection of metallo-β-lactamase gene ( blaIMP) in gram-negative rods resistant to broad-spectrum β-lactams. J. Clin. Microbiol. 34: 29092913.
60. Toleman, M. A.,, D. Biedenbach,, D. M. C. Bennett,, R. N. Jones, and, T. R. Walsh. 2005. Italian metalloβ-lactamases: a national problem? Report from the SENTRY Antimicrobial Surveillance Programme. J. Antimicrob. Chemother. 55: 6170.
61. Villar, H. E.,, F. Danel, and, D. M. Livermore. 1997. Permeability to carbapenems of Proteus mirabilis mutants selected for resistance to imipenem or other β-lactams. J. Antimicrob. Chemother. 40: 365370.
62. Vourli, S.,, P. Giakkoupi,, V. Miriagou,, E. Tzelepi,, A. C. Vatopoulos, and, L. S. Tzouvelekis. 2004. Novel GES/IBC extended-spectrum beta-lactamase variants with carbapenemase activity in clinical enterobacteria. FEMS Microbiol. Lett. 234: 209213.
63. Walsh, T. R.,, A. Bolmström,, A. Qwärnström, and, A. Gales. 2002. Evaluation of a new Etest for detecting metallo-β-lactamases in routine clinical testing. J. Clin. Microbiol. 40: 27552759.
64. Weber, D. J.,, R. Raasch, and, W. A. Rutala. 1999. Nosocomial infections in the ICU. Chest 115 (Suppl.): 34S41S.
65. Woodford, N.,, P. M. Tierno, Jr.,, K. Young,, L. Tysall,, M.-F. I. Palepou,, E. Ward,, R. E. Painter,, D. F. Suber,, D. Shungu,, L. L. Silver,, K. Inglima,, J. Kornblum, and, D. M. Livermore. 2004. Outbreak of Kleb siella pneumoniae producing a new carbapenem-hydrolyzing class A β-lactamase, KPC-3, in a New York medical center. Antimicrob. Agents Chemother. 48: 47934799.
66. Yan, J.-J.,, J.-J. Wu,, S.-H. Tsai, and, C.-L. Chuang. 2004. Comparison of the double-disk, combined disk, and E-test methods for detecting metallo-β-lactamases in gram-negative bacilli. Diagn. Microbiol. Infect. Dis. 49: 511.
67. Yan, J.-J.,, W.-C. Ko,, C.-L. Chuang, and, J.-J. Wu. 2002. Metallo-β-lactamase-producing Enterobacteriaceae isolates in a university in Taiwan: prevalence of IMP-8 in Enterobacter cloacae and first identification of VIM-2 in Citrobacter freundii. J. Antimicrob. Chemother. 50: 503511.
68. Yan, J.-.J.,, W.-C. Ko,, S.-H. Tsai,, H. M. Wu, and, J.-J. Wu. 2001. Outbreak of infection with multidrugresistant Klebsiella pneumoniae carrying blaIMP-8 in a university medical center in Taiwan. J. Clin. Microbiol. 39: 44334439.
69. Yigit, H.,, A. M. Queenan,, G. J. Anderson,, A. Domenech-Sanchez,, J. W. Biddle,, C. D. Steward,, S. Alberti,, K. Bush, and, F. C. Tenover. 2001. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45: 11511161.
70. Yigit, H.,, G. J. Anderson,, J. W. Biddle,, C. D. Steward,, J. K. Rasheed,, L. L. Valera,, J. E. McGowen, Jr., and, F. C. Tenover. 2002. Carbapenem resistance in a clinical isolate of Enterobacter aerogenes is associated with decreased expression of OmpF and OmpC porin analogs. Antimicrob. Agents Chemother. 46: 38173822.
71. Yigit, H.,, A. M. Queenan,, J. K. Rasheed,, J. W. Biddle,, A. Domenech-Sanchez,, S. Alberti,, K. Bush, and, F. C. Tenover. 2003. Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing β-lactamase KPC-2. Antimicrob. Agents Chemother. 47: 38813889.


Generic image for table
Table 1.

Class B metallo-β-lactamases found in

Citation: Bratu S, Quale J. 2007. Carbapenem Resistance in and Other Members of the Family , p 181-197. In Scheld W, Hooper D, Hughes J (ed), Emerging Infections 7. ASM Press, Washington, DC. doi: 10.1128/9781555815585.ch10
Generic image for table
Table 2.

Class A carbapenem-hydrolyzing β-lactamases found in

Citation: Bratu S, Quale J. 2007. Carbapenem Resistance in and Other Members of the Family , p 181-197. In Scheld W, Hooper D, Hughes J (ed), Emerging Infections 7. ASM Press, Washington, DC. doi: 10.1128/9781555815585.ch10
Generic image for table
Table 3.

Kinetic parameters of various carbapenem-hydrolyzing β-lactamases

Citation: Bratu S, Quale J. 2007. Carbapenem Resistance in and Other Members of the Family , p 181-197. In Scheld W, Hooper D, Hughes J (ed), Emerging Infections 7. ASM Press, Washington, DC. doi: 10.1128/9781555815585.ch10
Generic image for table
Table 4.

Susceptibility results for 62 KPC-possessing isolates

Citation: Bratu S, Quale J. 2007. Carbapenem Resistance in and Other Members of the Family , p 181-197. In Scheld W, Hooper D, Hughes J (ed), Emerging Infections 7. ASM Press, Washington, DC. doi: 10.1128/9781555815585.ch10

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error